Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot2 - STU 1 ballot International flag

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot2 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Example Group: InterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists

Generated Narrative: Group 236532

version: 68; Last updated: 2025-03-20 18:40:09+0000

Profile: ConceptualExposureDefinition

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

RelatesTo

  • type: part-of
  • targetReference: MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

url: https://fevir.net/resources/Group/236532

identifier: FEvIR Object Identifier/https://fevir.net/FOI/236532, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-intervention-85390-I-85789

name: Glucagon_Like_Peptide_1_GLP_1_receptor_agonists85390_I_85789

title: InterventionDefinition: Glucagon-Like Peptide-1 (GLP-1) receptor agonists

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

This Group Resource is referenced in an example for the EBMonFHIR Implementation Guide.

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System evidence-communication: Evidence CommunicationConceptualExposureDefinition

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

membership: Conceptual